TCTMD
Talking Points
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe.06f763f0-76e5-11f0-bb7c-8557ae1d8a8b
Wo hören?
Podcasts in der App Replaio Radio Bald verfügbarPodcasts kommen bald in die App. Installiere sie jetzt und erlebe als Erster einen ganz neuen Blick auf Podcasts
Kostenlos installieren
Android 5 Mio.+ Downloads · Bewertung 4,8
iOS bald
Folgen
Episode 155: Two DCBs Go Head to Head in De Novo CAD 25.08.2022 12:14
C. Michael Gibson and Wan Azman Wan Ahmad discuss a sirolimus-versus a paclitaxel-coated balloon in de novo coronary lesions.
Episode 154: The EMPEROR-Preserved Trial 10.08.2022 5:14
C. Michael Gibson and Stefan Anker discuss the effects of empagliflozin on CV death and HF hospitalizations in patients with HFpEF, with and without diabetes.
Episode 153: iFR-SWEDEHEART at 5 Years 03.08.2022 6:30
C. Michael Gibson and Matthias Götberg review 5-year findings after iFR- versus FFR-guided PCI.
Episode 152: PRONOUNCE: Prostate Cancer Drugs and CVD 20.07.2022 10:24
Renato Lopes and C. Michael Gibson discuss PRONOUNCE comparing the cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and CVD.
Episode 151: Stopping Amputation Post-revascularization: Novel Data in Mitigation of Thrombosis Risk 06.07.2022 9:01
Desai and Anahita Dua discuss highlights from a CME program on reducing thrombosis risks in patients with PAD post-revascularization. Claim credit: https://bit.ly/3QTpBt6. Supported by an educational grant from Janssen Scientific Affairs, LLC.
Episode 150: The TOMAHAWK Trial 06.07.2022 4:26
C. Michael Gibson and Steffen Desch discuss whether immediate angiography is warranted after out-of-hospital cardiac arrest.
Episode 149: The OPTIMUM Trial 22.06.2022 5:23
C. Michael Gibson and David Kandzari discuss PCI outcomes among patients at prohibitive risk for CABG.
Episode 148: The MASTER DAPT Trial 08.06.2022 9:00
C. Michael Gibson and Marco Valgimigli discuss dual antiplatelet therapy after coronary stenting in high-bleeding-risk patients.
Episode 147: The EROSION III Trial 01.06.2022 12:15
C. Michael Gibson, Haibo Jia, and Jingbo Hou discuss whether OCT guidance could cut stent use in STEMI without plaque rupture.
Episode 146: The LIFE Trial 18.05.2022 8:15
C. Michael Gibson and Douglas Mann discuss sacubitril/valsartan in patients with advanced HFrEF.
Episode 145: PRAGUE 17: LAA Closure vs DOACs 04.05.2022 11:46
C. Michael Gibson and Pavel Osmancik review 3-year results with LAA closure versus a DOAC for patients with atrial fibrillation.
Episode 144: MASTER DAPT: High-Risk Patients 20.04.2022 6:49
C. Michael Gibson and Pieter C. Smits review outcomes in high-bleeding-risk patients also at high risk for thrombotic events who were randomized to abbreviated DAPT.
Episode 143: The ADAPTABLE Study: Patient-Centered Aspirin 06.04.2022 13:45
C. Michael Gibson discusses aspirin dosing and long-term effectivness with Schuyler Jones and Greg Merritt.
Episode 142: ISCHEMIA: Complete Revascularization and QoL 23.03.2022 6:38
C. Michael Gibson and Kreton Mavromatis discuss how completeness of revascularization impacts quality of life in stable ischemic heart disease patients.
Episode 141: The STRENGTH Study of Omega-3s 16.03.2022 12:56
C. Michael Gibson and Steven Nissen discuss the link between omega-3 fatty acid levels and MACE in patients with high cardiovascular risk.
Episode 140: The SWISS-APERO Trial 02.03.2022 4:03
C. Michael Gibson and Robert Galea discuss Amulet versus Watchman for LAA closure.
Episode 139: The 2021 ESC HF Guidelines 09.02.2022 11:15
C. Michael Gibson and Carolyn Lam discuss key updates to the European heart failure guidelines and how best to initiate medications to optimize outcomes.
Episode 138: The ATLANTIS Trial: DOACs in TAVI? 02.02.2022 14:54
C. Michael Gibson, Jean-Philippe Collet, and Gilles Montalescot and discuss apixiban after TAVI in the Atlantis trial.
Episode 137: Early Intrepid TMVR Results 12.01.2022 6:10
C. Michael Gibson and Firas Zahr discuss 30-day outcomes following transfemoral transseptal TMVR.
Episode 136: Two DCBs vs POBA in Coronary In-Stent Restenosis 05.01.2022 6:13
C. Michael Gibson and Bruno Scheller discuss 1-year outcomes of two parallel RCTs.
Episode 135: The ULTIMATE Trial 22.12.2021 5:52
Junjie Zhang and C. Michael Gibson discuss 3-year outcomes after IVUS- versus angiography-guided DES implantation.
Episode 134: The PROSPECT ABSORB Trial 08.12.2021 12:47
Gregg Stone and C. Michael Gibson discuss a randomized trial examining interventional treatment of vulnerable plaques.
Episode 133: The COBRA-REDUCE Trial 02.12.2021 9:25
Robert Byrne and C. Michael Gibson discuss a randomized trial of a thromboresistant Polyzene F-coated stent with 14-day DAPT in high-bleeding-risk patients.
Episode 132: The RIVER Trial 10.11.2021 8:58
Otavio Berwanger and C. Michael Gibson discuss rivaroxaban versus warfarin in patients with bioprosthetic mitral valves and atrial fibrillation or flutter.
Episode 131: The SCOPE II Trial 03.11.2021 10:04
Corrado Tamburino and C. Michael Gibson discuss a randomized trial of two self-expanding TAVR bioprostheses.
Ähnliche Podcasts
Höre den Podcast Talking Points in Replaio
Radio und Podcasts in einer App - kostenlos und ohne Anmeldung. Installiere sie noch heute und verpasse den Start nicht
Replaio ist kein Herausgeber von Podcasts; die Namen der Sendungen, Cover und Audioinhalte gehören ihren Autoren und werden über öffentliche RSS-Feeds verbreitet
